Riders · The University of Texas Health Science Center at San Antonio · Article III: Agencies of Education

Opioid Abuse Prevention and Treatment

Rider 6 in the 2024-25 Act, page III-207

This rider is not in the Introduced (Senate) or any later version.

Through the session

  1. 2024-25 Act In current law rider 6
  2. Introduced (Senate) Dropped
  3. Introduced (House) Not in this version
  4. Senate substitute Not in this version
  5. House substitute Not in this version
  6. House passed Not in this version
  7. Conference Not in this version
  8. 2026-27 Act Not in this version

Pick any two steps to compare their wording.

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium 6 First version — Page III-207
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) Not in this version
Introduced (House)House Bill 1 as introduced (LBB recommended, House) Not in this version
Senate substituteCommittee Substitute for Senate Bill 1 Not in this version
House substituteHouse Committee Substitute for Senate Bill 1 Not in this version
House passedSenate Bill 1 as passed the second house Not in this version
ConferenceConference Committee Report for Senate Bill 1 Not in this version
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium Not in this version
Full text of each wording

2024-25 Act

Source, page III-207

Opioid Abuse Prevention and Treatment. Out of funds appropriated above in Strategy E.2.1, Opioid Abuse Prevention, $9,067,982 in fiscal year 2024 and $9,067,982 in fiscal year 2025 in one-time funding from GR-Dedicated Account No. 5189 shall be used to support overdose prevention, education, and overdose reversal medication. This support includes funding for overdose reversal medication access for law enforcement, distribution through health care providers, educational programming and distribution through schools, and distribution through community organizations. Any unexpended balances at the end of fiscal year 2024 are appropriated for the same purposes for fiscal year 2025.